NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, ...

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies ...

NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”) , a multi–Phase 2 clinical-stage biopharmaceutical company developing novel therapies for central nervous system (CNS) cancers today ...

The latest announcement is out from NeOnc Technologies Holdings, Inc. ( ($NTHI) ). On November 7, 2025, NeOnc Technologies Holdings, Inc.

During the call, members of the NTHI management team and independent members of the company’s Scientific Advisory Board (SAB) will present data updates from the Company’s ongoing Phase 1/2a NEO100-1 ...

In a town on the shores of Lake Geneva sit clumps of living human brain cells for hire. These blobs, about the size of a ...

It's an unpleasant feeling for us, but is failure necessary for success? A world champion athlete and Duke professor explain ...

Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society ...

Cornell researchers have developed a powerful new biosensor that reveals, in unprecedented detail, how and where ...

Sea urchins look like an inanimate bundle of needles, but a closer look at these alien-like creatures reveals a surprisingly ...

In the brain, highly specific connections called synapses link nerve cells and transmit electrical signals in a targeted manner. Despite decades of research, how synapses form during brain development ...

From translating thoughts into words to allowing paralyzed people to walk, the field of neurotechnology has been quietly ...